Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Ortoma

10.02 SEK-1.96 %20/11 17:29
Less than 1K followers

ORT B

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
-1.96 %
+40.14 %
+25.72 %
+17.06 %
-24.50 %
-28.68 %
+12.27 %
-58.76 %
+236.81 %

Ortoma operates in the medical technology sector. The company develops surgical systems for implant treatment. The technology is based on 3D models and is mainly used to plan and position implants such as hip, knee and back surgery. The products are used by orthopaedic surgeons and in various surgeries, and the business is based on research and development within the field. The company has its headquarters in Gothenburg.

Read more
Market cap
468.8M SEK
Turnover
457.17K SEK
Revenue
64.64M
EBIT %
-30.19 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Research
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
25/2
2027

Annual report '26

20/5
2027

General meeting '27

20/5
2027

Interim report Q1'27

Press release2026-11-06 11:36

DNB Carnegie Access: Ortoma: Poised for accelerated sales growth – Q3 review

Ortoma
Press release2026-11-05 17:10

DNB Carnegie Access: Ortoma - Q3 (26) - Earnings Call

Ortoma
Press release2026-11-05 09:31

DNB Carnegie Access: Ortoma: Soft quarter, strong 2027 setup – Q3 initial comment

Ortoma

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
Followings and notifications on followed companies
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release2026-11-05 08:00

Ortoma AB publicerar delårsrapport för det tredje kvartalet 2026

Ortoma
Press release2026-10-27 06:48

DNB Carnegie Access: Ortoma: Secures breakthrough commercial order from partner

Ortoma
Regulatory press release2026-10-26 17:59

Ortoma erhåller orders om cirka 173 MSEK avseende 125 OTS™ Hip-system med tillhörande komponenter

Ortoma
Regulatory press release2026-10-26 10:51

Valberedning utsedd inför Ortomas årsstämma 2027

Ortoma
Press release2026-08-20 13:15

DNB Carnegie Access: Ortoma – Närmar sig lansering på nyckelmarknader

Ortoma
Press release2026-07-30 17:34

DNB Carnegie Access: Ortoma: On track, but investor confidence takes a hit – Q2 review

Ortoma
Press release2026-07-30 09:28

DNB Carnegie Access: Ortoma: Strong sales, higher costs – Q2 initial comment

Ortoma
Regulatory press release2026-07-30 08:00

Ortoma AB publicerar delårsrapport april – juni 2026

Ortoma
Press release2026-07-06 08:47

DNB Carnegie Access: Ortoma: Temperature is rising – Q2 preview

Ortoma
Regulatory press release2026-07-03 09:06

Ortoma erhåller större order från sin globala partner avseende Europa, USA och Japan inför den fortsatta kommersialiseringen av OTS™ Hip

Ortoma
Regulatory press release2026-05-21 16:45

Kommuniké från årsstämma i Ortoma AB

Ortoma
Regulatory press release2026-05-21 07:30

Ortoma AB publicerar delårsrapport för det första kvartalet 2026

Ortoma
Regulatory press release2026-04-22 14:30

Ortoma AB publicerar årsredovisning 2025

Ortoma
Regulatory press release2026-04-17 14:18

Kallelse till årsstämma i Ortoma AB

Ortoma
Regulatory press release2026-04-17 13:52

Valberedningens förslag till årsstämman 2026

Ortoma
Regulatory press release2026-04-16 19:09

Ortomas företrädesemission övertecknad

Ortoma
Regulatory press release2026-04-16 19:09

Ortoma’s rights issue oversubscribed

Ortoma